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improvement in survival, as well as a complete nodal
staging of the lung carcinoma. In fact, it is widely rec-
ognized that precise information regarding nodal status
obtained by systematic dissection provides the most reli-
able information regarding prognosis and also enables
optimal postoperative treatment, the evaluation of proto-
col eligibility, and comparisons among different institu-
tions. The prognostic impact (improvement of local con-
trol and postoperative survival) has yet to be determined,
however, although retrospective studies have suggested
that systematic mediastinal dissection may improve the
prognosis.1,2 Recently Izbicki and associates3 performed
a randomized controlled trial in which they compared
systematic mediastinal lymphadenectomy with medi-
astinal lymph node sampling for 169 patients with
non–small cell lung cancer without overt lymph node
L ymph node dissection for lung cancer is both an oldand a new issue in the thoracic surgical community.
Complete hilar and mediastinal lymphadenectomy,
which is also called radical systematic mediastinal
lymph node dissection, is a local surgical option that
seeks to achieve better local control, with subsequent
Background: Complete lymphadenectomy of the mediastinum is advised
for patients with lung cancer to provide prognostic information and pos-
sible survival benefit. The proper extent of dissection should be further
defined. Method: The lymphatic metastatic patterns according to the pri-
mary site and prognoses were retrospectively analyzed in 166 patients
with non–small cell carcinoma who underwent at least lobectomy with
hilar and mediastinal lymphadenectomy. All patients had histologically
proven mediastinal metastasis (pN2). Results: Among 54 right upper lobe
tumors the most common site of metastasis was the lower pretracheal
station (74%), whereas metastases to the subcarinal station were seen
only in 13%. Among 8 patients with right middle lobe tumors and 41
patients with right lower lobe tumors, both superior mediastinal and
subcarinal stations were involved. The 34 left upper segment tumors
metastasized to the aorticopulmonary window most commonly (71%)
and to the subcarina only in 12% of cases. Inversely, the 10 left lingular
tumors metastasized to the subcarina most commonly (50%) and to the
aorticopulmonary window only in 20% of cases. Among 44 left lower
lobe tumors the subcarinal station was most common for metastasis
(58%), with infrequent metastases to the aorticopulmonary window.
The 5-year survival for all 166 patients was 35%. Patients with single-
station and single-node metastases had a significantly better prognosis
than those with more extensive metastases. Right lower lobe tumors
with superior mediastinal metastasis carried a particularly poor 5-year
survival of only 4.1%. Comment: Subcarinal lymphadenectomy is not
always necessary for tumors of the right upper lobe and left upper seg-
ment. For tumors of other lobes both superior mediastinal dissection
and subcarinal dissection are advised. However, superior mediastinal
metastasis should be recognized as an indicator of poor prognosis in
tumors of both lower lobes. (J Thorac Cardiovasc Surg 1999;117:1102-11)
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involvement. They found no difference between the 2
groups in disease-free survival or overall survival; how-
ever, their subset analysis in patients with limited medi-
astinal lymph node metastases suggested that a system-
atic lymphadenectomy may improve the prognosis.
These results are not yet conclusive and require confir-
mation. The attitude of surgeons toward possible medi-
astinal lymph node metastasis in lung carcinomas there-
fore currently varies from institution to institution.
Surgical options include nodal sampling only,4 radical
systematic lymph node dissection,1,2,5 and ultraradical
lymph node dissection of bilateral mediastinum through
a median sternotomy.6
The concept of systematic lymph node dissection of
the mediastinum for thoracic malignant tumors origi-
nates in the report by Cahan in 1960.7,8 He proposed a
lobectomy instead of pneumonectomy, which was then
a standard surgical option, with en bloc resection of the
mediastinum for patients at poor risk, and called this
procedure radical lobectomy. His original technique
for dissection was accepted as optimal and has been
performed ever since by thoracic surgeons, although it
was not based on a detailed analysis of metastasis at
each mediastinal location (lymph node mapping
became available 10 years later).9 With the accumula-
tion of data, a reevaluation of the mediastinal dissec-
tion, especially in terms of extent, may be necessary.
In this study we retrospectively reviewed the preva-
lences of lymph node metastases at each mediastinal
site among patients with N2 disease, especially with
respect to the lobe of the primary tumor. We examined
the prognosis of patients with respect to metastases at
certain sites in the mediastinum. On the basis of these
results we tried to determine the proper lobe-specific
extent of mediastinal dissection.
Patients and methods
During the 10-year period from 1987 to 1997, 1610
patients underwent pulmonary resection for lung cancer at
the National Cancer Center Hospital in Tokyo. Among these
we retrospectively analyzed the pattern of lymph node metas-
tasis and the prognosis in 166 patients with a non–small cell
histologic type as a lung carcinoma and histologically proven
mediastinal lymph node metastasis (pN2) after a careful
pathologic examination of all the dissected lymph nodes. All
the tumors were resected by pulmonary resection (at least
lobectomy) and systematic hilar and mediastinal lymph node
dissection as described elsewhere10 and were categorized as
either T1, T2, or T3.11 The following were criteria for exclu-
sion from this study: tumors with small cell or low-grade
malignant histologic type; T4 tumors, including those with
Table I. Patient characteristics
No. %
Sex
Male 123 74.1
Female 43 25.9
Histologic type
Adenocarcinoma 96 57.8
Squamous cell carcinoma 55 33.1
Large cell carcinoma 13 7.8
Adenosquamous carcinoma 2 1.3
Tumor size (cm)
≤2.0 19 11.4
2.0-3.0 147 88.6
Postoperative T status (pT)
T1 42 25.3
T2 87 52.4
T3 37 22.3
Preoperative N status (cN)
N0 67 40.4
N1 30 18.1
N2 66 39.7
N3 3 1.8
Tumor location
Right upper lobe 54 32.5
Right middle lobe 8 4.8
Right lower lobe 41 24.7
Left upper lobe 44 26.5
Left lower lobe 19 11.5
Operation
Pneumonectomy 48 28.9
Bilobectomy 14 8.4
Lobectomy 104 62.7
Curability
Complete 150 90.4
Incomplete 16 9.6
Table II. Lymph node location
Station 
Region No. Station name
N2 node Superior 1 Highest mediastinal
mediastinal
2 Paratracheal
3 Lower pretracheal
4 Tracheobronchial angle
Aortic 5 Aorticopulmonary 
window
6 Para-aortic (ascending 
aorta)
Inferior 7 Subcarinal
mediastinal
8 Paraesophageal
9 Pulmonary ligament
N1 node Hilar 10 Hilar
11 Interlobar
12 Lobar
Intrapulmonary 13 Segmental
14 Subsegmental
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malignant effusion and pleural dissemination; tumors with
distant metastatic disease; resection procedures less than
lobectomy for the primary tumor (segmentectomy or wedge
resection); and lack of hilar and mediastinal lymphadenecto-
my. Excluded patients comprised 18% of the total. The
patients ranged in age from 29 to 83 years (median 60.5
years). One hundred twenty-three patients were male and 43
were female. Most of the patients underwent a physical
examination, chest radiography, chest computed tomograph-
ic scan, bone scintigraphy, and abdominal ultrasonography
for staging and the evaluation of resectability before the oper-
ation. The clinical characteristics of these 166 patients are
presented in Table I. Resected specimens were examined his-
tologically, and their histologic type was determined accord-
ing to the World Health Organization classification12 as ade-
nocarcinoma, squamous cell carcinoma, large cell carcinoma,
or adenosquamous carcinoma.
Analysis of lymph node metastasis. The extent of lymph
node metastasis was precisely recorded station by station.
The median number of lymph nodes resected and examined
was 21 per patient (range 5-50 per patient). The locations of
intrapulmonary (stations 13 and 14, N1), hilar (stations 10-
12, N1), and mediastinal (stations 1-9, N2) lymph nodes were
expressed according to the lymph node map for lung cancer
proposed previously (Table II).9 Mediastinal stations were
categorized as superior mediastinal (stations 1 and 4), aortic
(stations 5 and 6), and inferior mediastinal (stations 7-9). The
number of metastatic nodes and their percentage were deter-
mined according to the lobe in which the primary tumor was
located. For tumors of the left upper lobe the metastases were
further analyzed independently according to the upper and
lingular segments.
Mode of lymph node metastasis. Special types of lymph
node metastasis to the mediastinum were also defined. A
metastasis was considered to be a skip metastasis if any of the
mediastinal lymph nodes were involved by the tumor without
hilar or intrapulmonary node metastasis. Single-station
metastasis was defined as when only a single station in the
mediastinum was involved, regardless of hilar node metasta-
sis. Single-node metastasis was defined as when only a single
node in the mediastinum was involved.
Recurrence and prognosis. Cancer recurrence was care-
fully divided into 2 categories according to the site of initial
recurrence: locoregional and distant. Locoregional recur-
rence was defined as any recurrent disease within the ipsilat-
eral hemithorax, mediastinum, or supraclavicular lymph
nodes. All other sites of recurrence were referred to as distant
metastases. The cause of death was recorded as either cancer
related, related to other disease, or unknown. The survival
was calculated by the Kaplan-Meier life table method13 and
comparisons were made by a log rank test14 in which the ini-
tial day of treatment was the day of the operation. A death
that was not due to cancer was considered to be a censored
case. A c 2 test was used to compare the prevalence.
Results
Lymph node metastases according to location of
the primary tumor
Right upper lobe. The most common site of involve-
ment for tumors of the right upper lobe (n = 54
patients; Table III) was the lower pretracheal station
(station 3), at which 40 patients (74%) had metastases.
The pretracheal station was also the most common site
for single-station (39%) and single-node (22%) metas-
tases. Overall, 53 of 54 patients (98.1%) had metas-
tases in at least 1 of the superior mediastinal stations
from 1 through 4. In contrast, the subcarinal station
(station 7) was involved in only 7 patients (13%), 6 of
whom had both subcarinal and superior mediastinal
node involvement (multiple-station involvement). Only
1 patient (1.9%) showed metastasis to the subcarinal
station without superior mediastinal involvement, and
this patient showed hilar node involvement.
Right middle lobe. The superior mediastinal and sub-
carinal stations were equally involved by tumors of the
right middle lobe (n = 8 patients; Table IV). Among
these the subcarinal node was involved most common-
ly (n = 7 patients, 88%), followed by the lower pretra-
cheal station (n = 6 patients, 75%). Single-station
metastases occurred in only 3 patients (38%); 2 of
these occurred in the subcarinal station and 1 occurred
in the pretracheal station.
Right lower lobe. The most common site of metasta-
Table III. Lymph node metastases among 54 patients with right upper-lobe tumors
Single-station Single-node 
Metastases metastases metastases
Lymph node station No. % No. % No. %
1 15 27.8 1 1.9 1 1.9
2 4 7.4 2 3.7 1 1.9
3 40 74.1 21 38.9 12 22.2
4 16 9.6 9 16.7 9 16.7
7 7 13.0 1 1.9 1 1.9
Right hilar and intrapulmonary nodes 30 55.6 — — — —
Total 54 100 34 63.0 24 44.4
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sis for tumors of the right lower lobe (n = 41 patients;
Table V) was the lower pretracheal station (station 3, n
= 27 patients, 75%), followed by the subcarinal station
(n = 24 patients, 59%). One of the superior mediastinal
stations from 1 through 4 was involved in 31 patients
(76%). Furthermore, metastasis occurred most com-
monly at the subcarinal station in patients with single-
station metastasis (n = 10/21 patients, 48%). The
remaining cases of single-station metastasis (n = 11/21
patients, 52%) occurred in superior mediastinal stations
1 through 4. This indicates the existence of lymphatic
pathways from the lower lobe to the superior medi-
astinum that do no pass through the subcarinal station.
Left upper lobe. The most common site of metastasis
in tumors of the left upper lobe (n = 44 patients; Table
VI) was the aorticopulmonary window (n = 26 patients,
59%), followed by the para-aortic station (n = 14
patients, 32%). Involvement of the subcarinal or lower
Table IV. Lymph node metastases among 8 patients with right middle-lobe tumors
Single-station Single-node 
Metastases metastases metastases
Lymph node station No. % No. % No. %
1 3 37.5 0 0 0 0
2 0 0 0 0 0 0
3 6 75 1 12.5 0 0
4 1 12.5 0 0 0 0
7 7 87.5 2 25 2 25
Right hilar and intrapulmonary nodes 7 87.5 — — — —
Total 8 100 3 37.5 2 25
Table V. Lymph node metastases among 41 patients with right lower-lobe tumors
Single-station Single-node 
Metastases metastases metastases
Lymph node station No. % No. % No. %
1 12 29.3 2 4.9 1 2.4
2 1 2.4 0 0 0 0
3 27 65.9 8 19.5 3 7.3
4 6 14.6 1 2.4 1 2.4
7 24 58.5 10 24.4 9 22.0
8 0 0 0 0 0 0
9 4 9.8 0 0 0 0
Right hilar and intrapulmonary nodes 36 87.8 — — — —
Total 41 100 21 51.2 14 34.1
Table VI. Lymph node metastases among 44 patients with left upper-lobe tumors
Single-station Single-node 
Metastases metastases metastases
Lymph node station No. % No. % No. %
1 1 2.3 0 0 0 0
2 8 18.2 1 2.3 0 0
3 6 13.6 0 0 0 0
4 12 27.3 4 9.1 1 2.3
5 26 59.1 11 25 9 20.5
6 14 31.8 4 9.1 3 6.8
7 9 20.5 5 11.4 5 11.4
Left hilar and intrapulmonary nodes 37 84.1 — — — —
Total 44 100 25 56.8 18 40.9
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mediastinal stations was relatively rare (21% and 0%,
respectively). Single-station metastasis occurred in 25
patients (57%); the station of the aorticopulmonary
window was most often involved (n = 11 patients,
25%). The subcarinal station was involved less com-
monly (n = 9 patients, 21%), and single-station metas-
tasis was seen in 5 of those patients. None of the sta-
tions in the lower mediastinum were involved.
Left upper segment versus lingular segment. Forty-
four patients with tumors of the upper lobe (Table VII)
were further analyzed according to the segment of the
primary tumor; there were 34 tumors in the upper seg-
ment and 10 in the lingular segment. There were dis-
tinctive differences in the pattern of lymphatic spread
between tumors of the upper and lingular segments.
Among tumors of the upper segment the most common
site of metastasis was the aorticopulmonary window (n
= 24 patients, 71%), followed by the para-aortic station
(n = 11 patients, 32%). Involvement of the subcarinal
station was seen in only 4 patients (12%), 3 of whom
had multiple-station metastases. Only 1 patient (2.9%)
had metastasis only at the subcarinal station. In con-
trast, the most common site of metastasis for tumors of
the lingular segment was the subcarinal station (n = 4
patients, 40%). The aorticopulmonary window and
para-aortic stations were involved in only 20% and
30% of cases, respectively.
Left lower lobe. The most common site of metastasis
for tumors of the left lower lobe (n = 19 patients; Table
VIII) was the subcarinal station (n = 11 patients, 58%),
Table VII. Lymph node metastases among 34 patients with upper-segment tumors and 10 patients with lingular-
segment tumors
Metastases (%) Single-station metastases (%) Single-node metastases (%)
Upper Lingular Upper Lingular Upper Lingular 
segment segment segment segment segment segment 
(n = 34) (n = 10) (n = 34) (n = 10) (n = 34) (n = 10)
Lymph node station No. % No. % No. % No. % No. % No. %
1 1 2.9 0 0 0 0 0 0 0 0 0 0
2 6 17.6 2 20 1 2.9 0 0 0 0 0 0
3 6 17.6 0 0 0 0 0 0 0 0 0 0
4 10 29.4 2 20 2 5.9 2 20 0 0 1 10
5 24 70.6 2 20 10 29.4 1 10 8 23.5 1 10
6 11 32.4 3 30 3 8.8 1 10 2 5.9 1 10
7 4 11.8 5 50 1 2.9 4 40 1 2.9 4 40
8 0 0 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 0 0 0
Left hilar and intrapulmonary nodes 30 88.2 7 70 — — — — — — — —
Total 34 100 10 100 17 50 8 80 11 32.4 7 70
Table VIII. Lymph node metastases among 19 patients with left lower-lobe tumors
Single-station Single-node 
Metastases metastases metastases
Lymph node station No. % No. % No. %
1 0 0 0 0 0 0
2 1 5.3 0 0 0 0
3 2 10.5 0 0 0 0
4 8 42.1 3 15.8 3 15.8
5 3 15.8 1 5.3 0 0
6 1 5.3 0 0 0 0
7 11 57.9 5 26.3 3 15.8
8 1 5.3 0 0 0 0
9 5 26.3 2 10.5 2 10.5
Left hilar and intrapulmonary nodes 7 36.8 — — — —
Total 19 100 11 57.9 8 42.1
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followed by the tracheobronchial station (n = 8
patients, 42%). The aorticopulmonary window and
para-aortic stations, which were commonly involved in
left upper lobe tumors, were not often involved (16%
and 5.3%, respectively). One of the superior mediasti-
nal or aortic stations was involved in 11 patients (58%).
Single-station metastases occurred in 11 patients
(58%). Although the most common site for single-sta-
tion metastasis was the subcarinal station (n = 5
patients, 26%), aortic stations were also involved in 4
patients (21%).
Single-station and single-node metastases. Single-
station metastases (Table IX) occurred in 94 patients
(57%). Regarding the site of single-station metastasis,
the lower pretracheal (n = 30 patients, 48%) and sub-
carinal (n = 17 patients, 28%) stations were common
among tumors on the right side, whereas the aorticopul-
monary window station (n = 12 patients, 38%) was
common among tumors on the left side. In 66 patients
(40%) the metastasis was limited to a single lymph node
of the mediastinum (single-node metastasis; Table IX).
Among tumors on the right side the lower pretracheal
node was the most common site of single-node metasta-
sis (n = 15 patients, 23%), followed by the subcarinal
node (n = 12 patients, 18%). Among tumors on the left
side the aorticopulmonary window (n = 9 patients, 14%)
was the most common site, followed by the subcarinal
node (n = 8 patients, 12%).
Skip metastases. Skip metastases occurred in 42
(25%) of the 166 patients. According to histologic
examination, adenocarcinoma (55%) was the most
common histologic type that metastasized in a skip
manner, followed by squamous cell carcinoma (36%)
and large cell carcinoma (9.5%).
Recurrence. One hundred six patients (64%) had
cancer recurrence after resection. Detailed data regard-
ing recurrence were not available for 6 patients. The
initial recurrence site was analyzed in the remaining
100 cases: 61 patients (61%) had distant relapse, 33
patients (33%) had locoregional relapse, and 6 patients
(6%) had both simultaneously. The initial sites of
recurrence are presented in Table X. As a local site of
recurrence the supraclavicular node (41%) was the
most common, whereas the lung (37%) was the most
common site for distant recurrence. The intervals
between the initial operation and the discovery of
recurrence varied from 83 to 2978 days. In 11 patients
(5.2%) recurrence was found 5 years or longer after
resection of the primary tumor. These 11 patients all
had adenocarcinomas.
Prognosis. The survival curve for all 166 patients is
shown in Fig 1. The overall 5-year survival was 35%.
Patients with single-station metastases had a signifi-
cantly better prognosis than did those with multiple-
Table IX. Single-station and single-node metastases by station site
Single-station metastases Single-node metastases
Right Left Right Left
No. % No. % Station No. No. % No. %
3 3.2 — — 1 2 3.0 — —
2 2.1 1 1.1 2 1 1.5 0 0
30 31.9 — — 3 15 22.7 — —
10 10.6 7 7.4 4 10 15.2 4 6.1
— — 12 12.8 5 — — 9 13.6
— — 4 4.3 6 — — 3 4.5
17 18.1 6 6.4 7 12 18.2 8 12.1
0 0 0 0 8 0 0 0 0
0 0 2 2.1 9 0 0 2 3.0
62 66.0 32 34.0 Subtotal 40 60.6 26 39.4
94 100 Total 66 100
Table X. Mode of recurrence in 100 patients with
recurrence
Mode of recurrence Location No.
Locoregional (n = 39*) Supraclavicular node 16
Mediastinal node 11
Pleural effusion or dissemination 6
Bronchial stump 4
Intrapulmonary metastasis 2
Distant (n = 67*) Lung 25
Brain 16
Bone 14
Liver 9
Adrenal 2
Others 1
*Six patients with simultaneous local and distant recurrences are included.
Fig 2. Survival curves of patients with single-station metastases
(MET) and multiple-station metastases. Five-year survivals for
patients with single-station metastases and multiple-station
metastases were 48% and 18%, respectively. Statistically sig-
nificant difference between groups was observed (log rank test,
P = .0006). Numbers in parentheses indicate number of patients
still at risk at every postoperative year.
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station metastases (P = .0006; Fig 2). Patients with sin-
gle-node metastases in the mediastinum also had a sig-
nificantly better prognosis than did those with multi-
ple-node metastases (P = .0002; Fig 3). Five-year
survivals for those with single-node and single-station
metastases were 55% and 48%, respectively.
Subcarinal node metastases. The prognoses of
patients with and without metastases at the subcarinal
station were compared for right upper lobe tumors (Fig
4). There was no significant difference in survival
between these 2 groups of patients.
Upper mediastinal metastasis. The prognoses of
patients with and without superior mediastinal node
metastasis were also compared for right lower lobe
tumors (Fig 5). Although no statistically significant dif-
ference in survival was observed, the survival of those
with superior mediastinal node metastasis was quite
poor, with a 5-year survival of 4.1%.
Discussion
Lymph node dissection of the pulmonary hilum and
mediastinum combined with lobectomy (radical lobec-
tomy) was first introduced by Cahan7 as an alternative
to pneumonectomy, which was respected as a standard
mode of surgery in those days; radical lobectomy was
originally indicated as a limited procedure for patients
at poor risk. Cahan7 stated, “We do not at present elect
to do a radical lobectomy for cancer of the lung as the
treatment of choice.” He first postulated that the extent
of dissection should be based on the lobe in which the
primary tumor was located. He also stated that bilobec-
tomy should be performed for tumors of the right mid-
dle or lower lobe. His proposal regarding the extent of
dissection was not based on a detailed analysis of the
prevalence of involvement in each mediastinal loca-
tion, however, although he had experience with this
surgical technique in 48 patients with lung cancer (n =
34 patients), metastasis (n = 9 patients), and benign
conditions (n = 5 patients). Data became available only
after surgeons adopted his technique, applied it practi-
cally, and described the metastatic status according to
the lymph node map. It is also important to note that
the original report of Cahan7 did not differentiate
between N1 and N2 nodes. It is quite surprising that he
was able to propose such a good extent of dissection
with the information available at that time.
The optimal extent of lymph node dissection should
be based on the prevalence of metastases to each medi-
astinal station and on the prognosis. Dissection of the
station with the least possibility of metastasis increases
the morbidity and mortality as well as the operative
time and blood loss while providing the least efficacy.
Because the lymphatic drainage route, and therefore
the prevalence of metastasis, is particular to the
anatomic location of the primary tumor (lobe), an
Fig 1. Survival curve for all 166 patients with lung carcino-
ma with mediastinal lymph node metastasis. Five-year sur-
vival was 35%. Numbers in parentheses indicate number of
patients still at risk at every postoperative year.
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analysis of lymphatic involvement according to the pri-
mary site is indispensable for determining the optimal
extent of dissection. The important points of this study
are as follows:
1. Dissection of the subcarinal node is not always
necessary for tumors of the right upper lobe and the left
upper segment because single-station metastases to this
station occur rarely (1.9% and 2.9%, respectively). In
this case dissection is indicated only when involvement
of the superior mediastinal station is noted by a frozen-
section examination during the operation.
2. The right middle and lower lobes can be resected
by lobectomy, not by bilobectomy, with complete erad-
ication of the lymphatic drainage route.
Fig 4. Survival curves of patients with and without subcarinal
node (station 7) metastases among 54 patients with right
upper lobe (RUL) tumors. There was no statistically signifi-
cant difference between groups (log rank test, P = .97).
Numbers in parentheses indicate number of patients still at
risk at every postoperative year.
Table XI. Recommendations regarding the extent of lymph node dissection according to the lobe of the primary
site of the tumor
Lymph node location
Superior Lower Hilar and 
Primary site mediastinal Aortic Subcarinal mediastinal inter lobar 
(lobe or segment) Study (1-4) (5-6) (7) (8-9) (10-11)
Right upper lobe Cahan7 Yes — No No Yes
Current study Yes — No No Yes
Right middle and lower lobe Cahan7 No — Yes Yes Yes
Current study Yes — Yes Yes Yes
Left upper segment Cahan7 Yes Yes No No Yes
Current study Yes* Yes No No Yes
Left lingular segment Cahan7 Yes Yes No No Yes
Current study Yes* Yes Yes No Yes
Left lower lobe Cahan7 No No Yes Yes Yes
Current study Yes* Yes Yes Yes Yes
*Because the highest mediastinal and lower pretracheal nodes are not usually accessible by left lateral thoracotomy, these nodes are not dissected.
Fig 3. Survival curves of patients with single-node metastases
(MET) and multiple-node metastases. Five-year survivals for
patients with single-node metastases and multiple-node
metastases were 55% and 20%, respectively. Statistically sig-
nificant difference between groups was observed (log rank
test, P = .0002). Numbers in parentheses indicate number of
patients still at risk at every postoperative year.
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3. Although the subcarinal station was commonly
involved in tumors of the lower lobe of both sides, the
lower station of the superior mediastinum or aortic sta-
tion was also involved without subcarinal involvement
in a significant number of cases (right side, 42%; left
side 42%).
4. Indeed, the higher prevalence of metastasis in
superior mediastinal stations seems unusual for right
lower lobe tumors. Looking at our results in detail,
however, we find that both single-node metastases and
single-station metastases were more common in the
subcarinal station than in the pretracheal station. This
finding indicates that the subcarinal station was the
principal first-step site of mediastinal spread of the
tumor cells and that lower pretracheal node involve-
ment by lower lobe tumors could be regarded as the
sign of considerable advancement of the disease. In this
series many advanced cases were included, maybe by
chance, and this could account for the higher preva-
lence of lower pretracheal metastases. This speculation
corresponds with the extremely poor prognosis (a sur-
vival of 4.l%) for patients with superior mediastinal
metastases of right lower lobe tumors (Fig 5).
5. In light of these findings, superior mediastinal
dissection is preferable for tumors of both lower lobes
because of the relatively higher prevalence. However,
the prognosis was extremely poor even after systematic
dissection, and this procedure is least likely to improve
survival.
Table XI shows the extents of dissection recom-
mended according to our results and those in Cahan’s
original proposal.7 Surprisingly, there were only small
differences between these suggestions, and our data
basically support Cahan’s original recommendations.7
Another important finding in this study was that
patients with single-station and single-node metastases
had a significantly better prognosis than those with
multiple-station and multiple-node metastases: 5-year
survivals were 48% and 55%, respectively. The better
prognosis of patients with single-station metastases has
been reported elsewhere.5,15 These findings indicate
that patients with N2 disease are a heterogeneous pop-
ulation with a considerably varied prognosis and that
patients with single-station or single-node metastasis
should be recognized as having “minimal N2 disease,”
with a different clinical course after surgical treatment
than that of those with other types of N2 disease. This
minimal N2 disease was otherwise categorized as N0
or N1 disease if systematic lymph node dissection was
not performed. Patients with minimal N2 disease
would theoretically best benefit from systematic lymph
node dissection, however, because minimal N2 disease
has the greatest chance of being a pure localized dis-
ease and cancer cells in the mediastinal nodes could be
eradicated by systematic lymph node dissection with-
out being overlooked. The better survival of these
patients with dissected minimal N2 disease suggests a
prognostic advantage of systematic lymph node dissec-
tion. Because a previous randomized study by Izbicki
and coworkers3 included only 24.7% patients with N2
disease, who would best benefit from lymphadenecto-
my, it is unclear whether that study would have been
able to detect an improvement in survival. Their subset
analysis among patients with N2 disease found that
patients undergoing systematic lymph node dissection
had a significantly better prognosis than did those
undergoing sampling alone, and this seems to be com-
patible with our speculations.
Most of the tumor recurrences after surgical treat-
ment were at distant organs, as noted in many previous
reports.16-18 This indicates that many cases of N2 dis-
ease are already systemic disease at the time of the
operation, with subclinical or latent systemic metas-
tases (micrometastases). The purpose of postoperative
or preoperative adjuvant chemotherapy is to control
these distant lesions, although the significance has yet
to be determined. Systematic lymph node dissection is
a purely local therapeutic option that has no impact on
controlling systemic micrometastases. Because there is
currently no diagnostic tool for detecting subclinical
micrometastases, however, we cannot differentiate
Fig 5. Survival curves of patients with and without superior
mediastinal node metastasis (from station 1 through station 4)
in 41 right lower lobe tumors. Five-year survival for patients
with superior mediastinal metastasis was 4.1%. There was no
statistically significant difference (log rank test, P = .55).
Numbers in parentheses indicate the number of patients still
at risk at every 1 year after surgery.
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between minimal N2 disease (local disease) and N2
disease with systemic micrometastases. When surgical
resection is indicated, regardless of whether it is a pri-
mary or an adjuvant operation, systematic lymph node
dissection of the extent discussed here should therefore
be performed.
This retrospective analysis yielded a lobe-specific
extent for systematic lymph node dissection according
to the prevalence at each mediastinal station. The
results support the extent originally proposed by
Cahan,7 with only minor changes. Questions regarding
mediastinal lymph node dissection must always be
answered according to whether survival is actually
improved. Considering that patients with N2 disease
can best benefit from lymph node dissection, a future
trial must be large enough to include patients with min-
imal N2 disease, because only they might have a
chance for cure. Otherwise, the results may always
remain inconclusive. Finally, mediastinoscopy has the
advantage in evaluating nodes on the contralateral side
that are not easily assessed during surgery. Therefore,
regardless of results of this study, the importance of
staging mediastinoscopy remains unchanged for the
purpose of better selection of surgical candidates by
exclusion of N3 or N2 spread of the disease.
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